Natera Inc. (($NTRA)) has held its Q4 earnings call. Read on for the main highlights of the call. Natera Inc. Reports Strong Financial Performance ...

Welcome, everyone, to Natera's 2024 fourth-quarter financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded, today, February 27, 2025. I would, ...

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Welcome everyone to Natera’s 2024 Fourth Quarter Financial ...

BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $190 from $185 and keeps a Buy rating on the shares. The company ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Natera (NTRA – Research Report), with a price target ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

Natera Inc (NTRA) reports a 53% revenue surge and outlines strategic initiatives amidst competitive pressures and ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsMike Brophy - Chief Financial ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for ...

We had a strong finish to the year, with excellent performance across the board,” said Steve Chapman, chief executive officer ...